Hough Pharma says it ‘continually provided efficacy, safety and variant data’ to TGA and prides itself on customer service
- Follow our Australia news live blog for the latest updates
- Get our free news app; get our morning email briefing
A pharmaceutical company supplying rapid antigen tests to Coles and Woolworths has rejected allegations it did not provide up-to-date safety and efficacy data and adequate support to consumers.
On Wednesday the Therapeutic Goods Administration (TGA) fined Hough Pharma $106,560 for “serial non-compliance” with regulatory requirements. All manufactures of therapeutic goods, including tests, drugs and medical devices approved for use in Australia, must continually provide safety and performance data to the TGA as requested.
Read the original article at The Guardian